feedback welcome

Clomipramine-tranylcypromine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
(One intermediate revision not shown)
Line 3: Line 3:
| to = tranylcypromine  
| to = tranylcypromine  
| stop =  
| stop =  
-
* '''Before day 1:''' gradually reduce dosage of clomipramine to a maximum of 75 mg/ day, when this dosage is > 75 mg/day.
+
{{TCAdecrease25p3d}}
-
* '''Day 1-3:''' reduce dosage of clomipramine to 50 mg/day.
+
{{14dwashout}}
-
* '''Day 4-7:''' reduce dosage of clomipramine to 25 mg/day.
+
-
* '''Day 8:''' stop administration of clomipramine.
+
| start =  
| start =  
-
* '''Day 8-21:''' a wash-out period of two weeks is necessary.
+
*a wash-out period of two weeks is necessary.
-
* '''Day 22-30:''' start administration of tranylcypromine in a low dosage of 20 mg/day for one week.
+
{{Starttranyl}}
-
* '''Day 31:''' after this week the dosage of tranylcypromine can be increased if necessary.
+
| caveat =  
| caveat =  
{{caveSS}}
{{caveSS}}
-
|info =
+
 
-
{{review}}
+
}}
}}

Current revision as of 11:44, 20 June 2016

Clomipramine
Type Antidepressant
Group TCA
links
ATC-code N06AA04
Medscape Clomipramine
PubChem 2801
PubMed Clomipramine
Kompas (Dutch) Clomipramine
Wikipedia Clomipramine
Tranylcypromine
Type Antidepressant
Group MAO-I
links
Medscape Tranylcypromine
PubChem 5530
PubMed Tranylcypromine
Wikipedia Tranylcypromine

Switch medication from clomipramine to tranylcypromine.

Nietinrijdenbord.png Stop clomipramine
Eenrichtingbord.png Start tranylcypromine
Letopbord.png Cave


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About